Education
About Us
Working with TipRanks
Follow Us
SkinBioTherapeutics plc (GB:SBTX)
:SBTX
RESEARCH TOOLSreports
SBTX Stock Chart & Stats
Day’s Range― - ―
52-Week Range9.00p - 27.50p
Previous CloseN/A
Volume282.34K
Average Volume (3M)1.78M
Market Cap
£42.38M
Enterprise Value38.41M
Total Cash (Recent Filing)£1.24M
Total Debt (Recent Filing)£1.03M
Price to Earnings (P/E)―
Beta0.06
Next Earnings
Dec 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding258,779,450
10 Day Avg. Volume733,998
30 Day Avg. Volume1,777,384
Financial Highlights & Ratios
PEG Ratio-0.76
Price to Book (P/B)8.20
Price to Sales (P/S)0.00
P/FCF Ratio-17.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£17.00Price Target Upside1.49% Upside
Rating ConsensusHold
Number of Analyst Covering0
SkinBioTherapeutics News
PremiumCompany Announcements
SkinBioTherapeutics Secures UK Distribution Deal with Superdrug
PremiumCompany Announcements
David Brierwood Increases Stake in SkinBioTherapeutics
PremiumCompany Announcements
SkinBioTherapeutics Raises £4.2 Million Through Share Issuance
PremiumCompany Announcements
SkinBioTherapeutics Secures Superdrug Deal and Raises £4.1m
PremiumCompany Announcements
SkinBioTherapeutics Appoints New Adviser and Broker
PremiumCompany Announcements
SkinBioTherapeutics Announces Change in Major Holdings
PremiumCompany Announcements
SkinBioTherapeutics Announces Change in Voting Rights StructureSBTX FAQ
What was SkinBioTherapeutics plc’s price range in the past 12 months?
SkinBioTherapeutics plc lowest share price was 9.00p and its highest was 27.50p in the past 12 months.
What is SkinBioTherapeutics plc’s market cap?
SkinBioTherapeutics plc’s market cap is £42.38M.
When is SkinBioTherapeutics plc’s upcoming earnings report date?
SkinBioTherapeutics plc’s upcoming earnings report date is Dec 04, 2025 which is in 131 days.
How were SkinBioTherapeutics plc’s earnings last quarter?
Currently, no data Available
Is SkinBioTherapeutics plc overvalued?
According to Wall Street analysts SkinBioTherapeutics plc’s price is currently Undervalued.
Does SkinBioTherapeutics plc pay dividends?
SkinBioTherapeutics plc does not currently pay dividends.
What is SkinBioTherapeutics plc’s EPS estimate?
SkinBioTherapeutics plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SkinBioTherapeutics plc have?
SkinBioTherapeutics plc has 258,779,450 shares outstanding.
What happened to SkinBioTherapeutics plc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of SkinBioTherapeutics plc?
Currently, no hedge funds are holding shares in GB:SBTX
SkinBioTherapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
£17.00 (1.49% Upside)
£17.00 (1.49% Upside)
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
43.95%
12-Months-Change
Fundamentals
Return on Equity
-63.28%
Trailing 12-Months
Asset Growth
73.26%
Trailing 12-Months
Company Description
SkinBioTherapeutics plc
SkinBioTherapeutics (SBTX) is a UK-based life sciences company specializing in the development of innovative skin health solutions. The company leverages its proprietary technology, SkinBiotix®, which is based on lysates derived from probiotic bacteria, to create products that enhance the health and appearance of the skin. SkinBioTherapeutics operates primarily in the dermatology and personal care sectors, targeting both therapeutic and functional skincare markets.